In this episode of The Health Edge Mark and John discuss important cardiovascular risk biomarkers for measurement and tracking.
In this episode of The Health Edge Mark and John discuss common single nucleotide polymorphisms (SNPs) commonly found on consumer-based gene analyses like 23 and Me. They discuss the implications for lifestyle, nutritional, and thoughtful supplementation interventions.
In this episode of The Health Edge Mark and John discuss the research linking lifestyle with breast cancer risk and prognosis.
In this episode of The Health Edge Mark and John discuss the current research linking the microbiome to human health. They review why we have fewer and less diverse “Fellow Travelers” and how we can begin to think about restoring this critical ecosystem legacy.
In this episode of The Health Edge Mark and John discuss the metabolic disruptors that increase the risk of Alzheimer’s and other “brain-related diseases”. The explore lifestyle interventions proven to restore many of these risk factors. Might Alzheimer’s be preventable or reversible? The research is suggesting a very surprising answer!
In this episode of The Health Edge Mark and John discuss the connection between mitochondrial function and the risk-progression of many chronic complex diseases. They explore the many “environmental” drivers and offer some lifestyle interventions to improve mitochondrial reserve-resilience.
In this episode of The Health Edge Mark and John discuss protein intake, sources, and health. They touch on:
- How much protein is sufficient for most
- What are the differences between plant and animal protein sources
- What are the benefits and risks of IGF-1 from a health perspective
Human conditions of insulin-like growth factor-I (IGF-I) deficiencyIGF-1 promotes the development and cytotoxic activity of human NK cellsInsulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk- pooled individual data analysis of 17
prospective studiesDemonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive declineInsulin-like growth factor-(IGF)-axis, inflammation, and glucose intolerance among older adults